| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |